Collaboration is a huge topic in healthcare today. The industry is evolving extremely fast, and while that brings with it plenty of opportunity, it also creates new challenges.
With 2024 well under way, influential conferences in London have given a barometer reading on the conditions in the European biopharma market, reports Richard Staines.
In a new white paper from the World Without Disease initiative, a 2024 update is provided of the current endeavours and developments that have occurred since inaugural discussions last year